Company Filing History:
Years Active: 2015
Title: Veronique Cerpentier: Innovator in Macrocyclic Protease Inhibitors
Introduction
Veronique Cerpentier is a notable inventor based in Loksbergen, Belgium. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of macrocyclic protease inhibitors for HCV (Hepatitis C Virus). With a total of two patents to her name, her work is recognized for its innovative approach to combating viral infections.
Latest Patents
Veronique's latest patents focus on processes and intermediates for preparing a macrocyclic protease inhibitor of HCV. The inventions relate to the cinchonidine salt, which is useful in the preparation of intermediates for creating a macrocyclic HCV inhibitor. These patents highlight her expertise in developing effective treatments for viral diseases.
Career Highlights
Veronique Cerpentier is currently employed at Janssen Pharmaceutica NV, a leading pharmaceutical company known for its commitment to innovation and healthcare solutions. Her work at Janssen has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout her career, Veronique has collaborated with esteemed colleagues such as Andras Horvath and Dominic Ormerod. These collaborations have further enhanced her research and have led to advancements in the field of protease inhibitors.
Conclusion
Veronique Cerpentier is a pioneering inventor whose work in macrocyclic protease inhibitors has the potential to make a significant impact on the treatment of HCV. Her contributions to the pharmaceutical industry exemplify the importance of innovation in healthcare.